dr. van cutsem on regorafenib for patients with colorectal cancer
Published 7 years ago • 558 plays • Length 24:26Download video MP4
Download video MP3
Similar videos
-
1:31
dr. eric van cutsem on regorafenib for metastatic colorectal cancer
-
1:39
dr. van cutsem discusses regorafenib for the treatment of patients with chemorefractory mcrc
-
5:31
practical advice for using regorafenib
-
3:54
colorectal cancer: patient follow-up with regorafenib
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
9:34
regorafenib in colorectal cancer
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
11:24
managing toxicities associated with regorafenib
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
1:04
dr. randall holcombe discusses regorafenib for metastatic colorectal cancer
-
5:53
redos trial: optimizing regorafenib dosing in metastatic colorectal cancer
-
1:21
dr. george demetri explains the side effects associated with regorafenib
-
10:02
role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
-
5:32
colorectal cancer: regorafenib patient selection and dosing
-
5:25
second-line and salvage treatment of metastatic colorectal cancer
-
11:36
panitumumab, regorafenib, and ziv-aflibercept in metastatic colorectal cancer